An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels

Erstveröffentlichung
2010
Metadata only
Search for full text
Beitrag zu einer Konferenz


Authors
Petzold, Axel
Chapman, Miles D.
Schraen, Susanna
Verwey, Nicolaas A.
Pasquier, Florence
et al.
Institutions
UKU. Klinik für Neurologie
Bezirkskrankenhaus Günzburg
Sonderforschungsbereich SFB 1279 Exploting the Human Peptidome for Novel Antimicrobial and Anticancer Agents
Published in
Experimental Neurology ; 223 (2010), 2, SI. - S. 432-438. - ISSN 0014-4886. - eISSN 1090-2430
Link to publication
https://dx.doi.org/10.1016/j.expneurol.2009.11.010
Conference
10th International Conference on Alzheimers Disease and Related Disorders, 2006-07-15 - 2006-07-16, Madrid
Keywords
Cerebrospinal fluid; CSF; tau; Dementia; CEREBROSPINAL-FLUID-TAU; FRONTOTEMPORAL LOBAR DEGENERATION; MILD COGNITIVE IMPAIRMENT; BETA-AMYLOID 1-42; BIOCHEMICAL MARKER; PHOSPHORYLATED-TAU; DIAGNOSTIC MARKER; REFERENCE VALUES; PROTEIN LEVELS
Dewey Decimal Group
DDC 610 / Medicine & health
Metadata
Show full item record